ArticleHemaSphere2022

Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy.

Ioannis Ntanasis-Stathopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.